Brain+ ApS (BRAINP) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.964x

Based on the latest financial reports, Brain+ ApS (BRAINP) has a cash flow conversion efficiency ratio of -0.964x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Dkr-13.93 Million ≈ $-2.18 Million USD) by net assets (Dkr14.45 Million ≈ $2.26 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Brain+ ApS - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Brain+ ApS's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read BRAINP total liabilities for a breakdown of total debt and financial obligations.

Brain+ ApS Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Brain+ ApS ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
REVITALIST L.A.W. LTD
F:4DO
N/A
National World PLC
LSE:NWOR
0.024x
Norrland Gold Corp
V:NORR
-0.074x
Octopus Aim VCT 2 PLC
LSE:OSEC
-0.006x
Vivanco Gruppe AG
F:VG0K
0.164x
Colefax Group
LSE:CFX
0.297x
Ondine Biomedical Inc
LSE:OBI
-0.665x
ALGERNON PHARMACEUT. A
F:AGW0
N/A

Annual Cash Flow Conversion Efficiency for Brain+ ApS (2017–2024)

The table below shows the annual cash flow conversion efficiency of Brain+ ApS from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Brain+ ApS worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 Dkr10.98 Million
≈ $1.72 Million
Dkr-9.25 Million
≈ $-1.45 Million
-0.842x +23.90%
2023-12-31 Dkr12.38 Million
≈ $1.94 Million
Dkr-13.71 Million
≈ $-2.14 Million
-1.107x -350.45%
2022-12-31 Dkr16.38 Million
≈ $2.56 Million
Dkr-4.03 Million
≈ $-629.80K
-0.246x +39.61%
2021-12-31 Dkr20.60 Million
≈ $3.22 Million
Dkr-8.38 Million
≈ $-1.31 Million
-0.407x -110.70%
2020-12-31 Dkr1.92 Million
≈ $300.09K
Dkr7.29 Million
≈ $1.14 Million
3.801x +74401.98%
2019-12-31 Dkr3.20 Million
≈ $500.19K
Dkr16.31K
≈ $2.55K
0.005x -99.56%
2018-12-31 Dkr6.24 Million
≈ $975.54K
Dkr7.29 Million
≈ $1.14 Million
1.169x +7.41%
2017-12-31 Dkr6.70 Million
≈ $1.05 Million
Dkr7.29 Million
≈ $1.14 Million
1.089x --

About Brain+ ApS

CO:BRAINP Denmark Health Information Services
Market Cap
$744.48K
Dkr4.76 Million DKK
Market Cap Rank
#30373 Global
#145 in Denmark
Share Price
Dkr0.00
Change (1 day)
+0.00%
52-Week Range
Dkr0.00 - Dkr0.02
All Time High
Dkr4.87
About

Brain+ A/S, a healthtech company, develops and commercializes technology solutions in dementia care primarily for cognitive stimulation therapy. The company is developing Ayla, a scalable dementia care platform that offers practical, human-centered, and clinically proven software-based dementia therapy and care solutions. It is also developing Ayla " your CST Assistant, a software-based dementia … Read more